Therapeutic angiogenesis using genetically engineered human endothelial cells

Cell therapy holds promise as a method for the treatment of ischemic disease. However, one significant challenge to the efficacy of cell therapy is poor cell survival in vivo. Here we describe a non-viral, gene therapy approach to improve the survival and engraftment of cells transplanted into ische...

Full description

Bibliographic Details
Main Authors: Cho, Seung-Woo (Author), Son, Sun Mi (Contributor), Park, Hyun-Ji (Author), Green, Jordan J. (Contributor), Bogatyrev, Said (Contributor), Mei, Ying (Contributor), Park, Sohyun (Contributor), Anderson, Daniel Griffith (Contributor), Langer, Robert S (Author), Yang, Fan (Author)
Other Authors: Harvard University- (Contributor), Massachusetts Institute of Technology. Department of Biology (Contributor), Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor), Langer, Robert (Contributor)
Format: Article
Language:English
Published: Elsevier, 2016-02-09T13:58:28Z.
Subjects:
Online Access:Get fulltext